Alexandra P Lebensohn
Overview
Explore the profile of Alexandra P Lebensohn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vocke C, Ricketts C, Pack S, Raffeld M, Hewitt S, Lebensohn A, et al.
J Med Genet
. 2024 Sep;
61(11):1026-1030.
PMID: 39317422
von Hippel-Lindau (VHL) is an autosomal-dominant hereditary tumour susceptibility disease associated with pathogenic germline variants in the tumour suppressor gene. VHL patients are at increased risk of developing multiple benign...
2.
Hu Z, Miettinen M, Quezado M, Lebensohn A, Aldape K, Agra M, et al.
J Thorac Oncol
. 2021 Oct;
17(3):461-466.
PMID: 34628055
BAP1 is a tumor suppressor gene implicated in DNA repair and cell growth. Individuals with germline BAP1 mutations are at a significantly increased risk for developing many different cancers including...
3.
Idos G, Kurian A, Ricker C, Sturgeon D, Culver J, Kingham K, et al.
JCO Precis Oncol
. 2021 Jul;
3.
PMID: 34322651
Purpose: Multiplex gene panel testing (MGPT) allows for the simultaneous analysis of germline cancer susceptibility genes. This study describes the diagnostic yield and patient experiences of MGPT in diverse populations....
4.
Culver J, Ricker C, Bonner J, Kidd J, Sturgeon D, Hodan R, et al.
Cancer
. 2020 Dec;
127(8):1275-1285.
PMID: 33320347
Background: Little is known about the psychological outcomes of germline multigene panel testing, particularly among diverse patients and those with moderate-risk pathogenic variants (PVs). Methods: Study participants (N = 1264)...
5.
Caswell-Jin J, Gupta T, Hall E, Petrovchich I, Mills M, Kingham K, et al.
Genet Med
. 2017 Jul;
20(2):234-239.
PMID: 28749474
PurposeWe examined racial/ethnic differences in the usage and results of germ-line multiple-gene sequencing (MGS) panels to evaluate hereditary cancer risk.MethodsWe collected genetic testing results and clinical information from 1,483 patients...